Rita Winn
Women's Health · Lone Tree, CONPI 1972000339
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Genmab U.S., Inc. at 27.8% of the total. 2025 is the largest year on record at $855, 2.9 times the $297 reported in 2021. Among women's health clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $30.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genmab U.S., Inc.$959
- GSK$621
- AstraZeneca$451
- Merck$371
- Eisai Inc.$255
- Astellas Pharma US Inc$131
- plus $659 from 15 others
What the payments were for
- Food & beverage$3,447100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genmab U.S., Inc. | 28 | $959 |
| GSK | 18 | $621 |
| AstraZeneca | 16 | $451 |
| Merck | 17 | $371 |
| Eisai Inc. | 7 | $255 |
| Astellas Pharma US Inc | 2 | $131 |
| AbbVie | 5 | $121 |
| Tempus AI, Inc | 3 | $77 |
| Hologic Sales And Service, LLC | 3 | $69 |
| Seagen Inc. | 1 | $65 |
| Myriad Genetic Laboratories, Inc. | 1 | $48 |
| Cumberland Pharmaceuticals, Inc. | 2 | $47 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Edwards Lifesciences | 1 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Innovation Technologies Inc | 1 | $32 |
| Aroa Biosurgery Incorporated | 1 | $25 |
| Pharmaand GmbH | 1 | $21 |
| Smith+Nephew | 1 | $20 |
| Teleflex LLC | 1 | $16 |
| Clovis Oncology, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,447 in reported general payments places this provider in the 95th percentile of 165 women's health providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $8,926 |
| Oxycodone Hcl | 22 | $96 |
Paid to pharmacies, not to this prescriber.
Other women's health in Lone Tree
- Julie MarshallLone Tree$12K
- Amanda RoyLone Tree$1K
- Elizabeth NordquistLone Tree$1K
- Hannah KuklaLone Tree$824
- Elizabeth JanichLone Tree$715
- Anita WolfeLone Tree$656
- Deanna WoodroffeLone Tree$610
- Jane Kass-WolffAurora$8K
- Hisae TsurumiAurora$6K
- Ladean MarshallDenver$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.